When is Protein Binding Important?

被引:60
作者
Heuberger, Jules [1 ]
Schmidt, Stephan [1 ]
Derendorf, Hartmut [1 ]
机构
[1] Univ Florida, Dept Pharmaceut, Gainesville, FL 32611 USA
关键词
protein binding; in vitro/in vivo correlations (IVIVC); drug interaction; pharmacokinetics; in vitro models; microdialysis; HEPATIC METABOLIC-CLEARANCE; DRUG-DRUG INTERACTIONS; IN-VITRO DATA; HUMAN LIVER-MICROSOMES; NONSPECIFIC-BINDING; INTRINSIC CLEARANCE; DISPLACEMENT INTERACTIONS; PHARMACOLOGICAL-ACTIVITY; CLINICAL-SIGNIFICANCE; INHALED CICLESONIDE;
D O I
10.1002/jps.23559
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present paper is an ode to a classic citation by Benet and Hoener (2002. Clin Pharm Ther 71(3): 115-121). The now classic paper had a huge impact on drug development and the way the issue of protein binding is perceived and interpreted. Although the authors very clearly pointed out the limitations and underlying assumptions for their delineations, these are too often overlooked and the classic paper's message is misinterpreted by broadening to cases that were not intended. Some members of the scientific community concluded from the paper that protein binding is not important. This was clearly not intended by the authors, as they finished their paper with a paragraph entitled: "When is protein binding important?" Misinterpretation of the underlying assumptions in the classic work can result in major pitfalls in drug development. Therefore, we revisit the topic of protein binding with the intention of clarifying when clinically relevant changes should be considered during drug development. (C) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102: 3458-3467, 2013
引用
收藏
页码:3458 / 3467
页数:10
相关论文
共 48 条
[1]   POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J].
AGGELER, PM ;
OREILLY, RA ;
LEONG, L ;
KOWITZ, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) :496-&
[2]   Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[3]   The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation [J].
Berezhkovskiy, Leonid M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (03) :1167-1183
[4]   Prediction of in vivo drug-drug interactions from in vitro data -: Factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4 [J].
Brown, Hayley S. ;
Galetin, Aleksandra ;
Hallifax, David ;
Houston, J. Brian .
CLINICAL PHARMACOKINETICS, 2006, 45 (10) :1035-1050
[5]   Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid [J].
Craig, WA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) :479-+
[6]   PROTEIN-BINDING OF ANTIMICROBIALS - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS [J].
CRAIG, WA ;
WELLING, PG .
CLINICAL PHARMACOKINETICS, 1977, 2 (04) :252-268
[7]   The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools [J].
De Buck, Stefan S. ;
Sinha, Vikash K. ;
Fenu, Luca A. ;
Gilissen, Ron A. ;
Mackie, Claire E. ;
Nijsen, Marjoleen J. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) :649-659
[8]   Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma [J].
Derendorf, H. ;
Nave, R. ;
Drollmann, A. ;
Cerasoli, F. ;
Wurst, W. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) :1042-1050
[9]   Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide [J].
Derendorf, Hartmut .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (06) :782-789
[10]  
EMA, 2012, EMA GUID INV DRUG IN